BioSpace News Archive

Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (Nasdaq:CYTO), a company dedicated to developing and commercializing RNA delivery technology for targets beyond the liver, today announced the publication of the detailed results from the NASAR clinical trial with Bentrio® nasal spray in seasonal allergic rhinitis (SAR).

In a move that is set to transform clinical reproductive medicine, GenEmbryomics Limited and Progenesis Inc, today announced a groundbreaking collaboration to enhance access to cutting-edge reproductive technologies.

Doheny Eye Institute announced that more than 25 of its scientists and clinician-scientists will present their latest research during the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, the premiere gathering for eye and vision scientists from across the globe.

Blue Mountain, the leader in GMP-compliant EAM (Enterprise Asset Management) software for life sciences, is pleased to announce the appointment of Jessica Brown as Global Head of Marketing and its newest addition to the executive team.

Regeneron Pharmaceuticals, Inc. announced new and updated data from its oncology and hematology pipeline will be shared across 17 presentations at the American Society of Clinical Oncology 2024 Annual Meeting, taking place from May 31 to June 5 in Chicago, IL.

2024 is a year of great expectations for the newly established PharmaNutra USA Corp, a US company based in Florida, wholly owned by PharmaNutra S.p.A. and dedicated to marketing and distributing the Group’s products in the United States.

AffyImmune Therapeutics, Inc., a clinical-stage biopharmaceutical company, announced an abstract detailing its affinity-tuned CAR T therapy AIC100 will be presented at the American Society of Clinical Oncology 2024 Annual Meeting, held May 31-June 4, at McCormick Place Convention Center in Chicago, IL.

Agenus Inc. announced an upcoming presentation from the Phase 1b trial of botensilimab in combination with balstilimab in patients with relapsed/refractory microsatellite stable colorectal cancer with no active liver metastases will be presented at the upcoming American Society of Clinical Oncology Meeting, to be held May 31 – June 4, 2024, in Chicago, IL.

Bicycle Therapeutics plc announced the acceptance of two abstracts for poster presentation at the 2024 American Society for Clinical Oncology Annual Meeting, taking place May 31-June 4 in Chicago.

Nuvation Bio Inc. announced that updated data from the Phase 2 TRUST-I clinical study evaluating taletrectinib in patients in China with ROS1-positive non-small cell lung cancer will be reported in an oral presentation at the 2024 American Society of Clinical Oncology Annual Meeting taking place May 31-June 4, 2024 in Chicago, Illinois.